Solara Active Pharma Sciences Q2 Results
- BSE: 541540
- NSE: SOLARA
- ISIN: INE624Z01016
- Sector: Biotechnology & Drugs
BSE
786.6
-11.80 (-1.48%)
-11.80 (-1.48%)Volume3.69 K
Updated: Mon 25 Nov, 2024 | 15:29:47
NSE
785.45-13.90 (-1.74%)
-13.90 (-1.74%)Volume78.64 K
Updated: Mon 25 Nov, 2024 | 15:31:29
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹346.95 Cr.(-4.55%)
- Operating Profit₹35.97 Cr.(113.47%)
- Profit After Tax₹8.01 Cr.(NA%)
- Operating Margin10.37%(611.08%)
Note: Comparison is on YoY basis
Quarterly - Solara Active Pharma Sciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 346.95 | 352.31 | -% | 425.24 | -% |
| Selling/ General/ Admin Expenses Total | 52.71 | 61.15 | -% | 64.12 | -% |
| Depreciation/ Amortization | 25.34 | 25.91 | -% | 26.21 | -% |
| Other Operating Expenses Total | 61.04 | 80.05 | -% | 85.96 | -% |
| Total Operating Expense | 310.98 | 359.10 | -% | 419.04 | -% |
| Operating Income | 35.97 | -6.79 | -% | 6.20 | -% |
| Net Income Before Taxes | 8.01 | -29.36 | -% | -17.06 | -% |
| Net Income | 8.01 | -19.55 | -% | -17.16 | -% |
| Diluted Normalized EPS | 2.22 | -5.43 | -% | -3.32 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST